1. System Prediction and Validation of TCM for Chronic Myeloid Leukemia Treatment from the Perspective of Low-Toxicity Chemotherapy: A Stilbene α-Viniferin Has a Proapoptotic Effect on K562 Cells via the Mitochondrial Pathway
   Bing-yang Chai et al, 2020, Evidence-Based Complementary and Alternative Medicine CrossRef
2. Repurposing Drugs as Novel Triple-negative Breast Cancer Therapeutics
   Amiya Das et al, 2022, Anti-Cancer Agents in Medicinal Chemistry CrossRef
3. Nanotechnology-mediated delivery of resveratrol as promising strategy to improve therapeutic efficacy in triple negative breast cancer (TNBC): progress and promises
   Javed Ahmad et al, 2024, Expert Opinion on Drug Delivery CrossRef
4. The Potential of Natural Products in the Treatment of Triple-negative Breast Cancer
   Danny Yu Jia Ke et al, 2022, Current Cancer Drug Targets CrossRef
5. Resveratrol in Cancer Treatment with a Focus on Breast Cancer
   Hamid Reza Gilasi et al, 2023, Current Molecular Pharmacology CrossRef
6. Natural Products and Their Bioactive Compounds as Breast Cancer Therapeutics
   Monika Rezacova, 2022, Handbook of Research on Natural Products and Their Bioactive Compounds as Cancer Therapeutics CrossRef
7. Arachidin-1, a Prenylated Stilbenoid from Peanut, Induces Apoptosis in Triple-Negative Breast Cancer Cells
   Sepideh Mohammadhosseinpour et al, 2022, International Journal of Molecular Sciences CrossRef
8. Autophagy induction using Resveratrol enhances the anti-cancer efficacy of Doxazosin in breast cancer cells.
   Ali Sami Ahmed Alhayali et al, 2023, Bionatura CrossRef
9. Unlocking the power of nanomedicine: the future of nutraceuticals in oncology treatment
   Madhav Singla et al, 2023, Frontiers in Nutrition CrossRef